Variant report

Variant	rs60849332
Chromosome Location	chr19:36351768-36351769
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr19:36348843..36352101-chr19:36356347..36359178,3	MCF-7	breast:
2	chr19:36346452..36348477-chr19:36350234..36352680,3	K562	blood:
3	chr19:36247691..36250491-chr19:36351522..36354287,2	MCF-7	breast:
4	chr19:36335712..36337227-chr19:36349133..36352127,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000126259	Chromatin interaction
ENSG00000161270	Chromatin interaction
ENSG00000167595	Chromatin interaction
ENSG00000004776	Chromatin interaction
ENSG00000105290	Chromatin interaction

Extended variants
information (count: 10 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs35854130	0.86[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:9 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv432045	chr19:35556260-36520760	Flanking Active TSS Enhancers Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	191 gene(s)	inside rSNPs	diseases
2	nsv911638	chr19:36265508-36537959	Enhancers Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	67 gene(s)	inside rSNPs	diseases
3	esv3526489	chr19:36306483-36741945	Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	114 gene(s)	inside rSNPs	diseases
4	esv3526490	chr19:36306483-36741945	Genic enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	114 gene(s)	inside rSNPs	diseases
5	esv1831737	chr19:36324324-36690874	Weak transcription Strong transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
6	esv3397651	chr19:36326933-36377725	Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	23 gene(s)	inside rSNPs	diseases
7	nsv833812	chr19:36331913-36507594	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
8	nsv833813	chr19:36341181-36499431	Flanking Active TSS Weak transcription Strong transcription Enhancers Bivalent Enhancer Genic enhancers ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	47 gene(s)	inside rSNPs	diseases
9	nsv911639	chr19:36342909-36365985	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Strong transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	16 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:38 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:36349400-36351800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr19:36349600-36353600	Genic enhancers	Pancreas	Pancrea
3	chr19:36349600-36358800	Weak transcription	Dnd41	blood
4	chr19:36349800-36351800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr19:36350800-36352400	ZNF genes & repeats	Spleen	Spleen
6	chr19:36351000-36353000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
7	chr19:36351200-36352400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
8	chr19:36351200-36352600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr19:36351200-36352600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
10	chr19:36351400-36351800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
11	chr19:36351400-36351800	Bivalent Enhancer	Right Ventricle	heart
12	chr19:36351400-36352000	Flanking Bivalent TSS/Enh	HepG2	liver
13	chr19:36351400-36352200	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
14	chr19:36351400-36352200	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr19:36351400-36352200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr19:36351400-36352200	Bivalent Enhancer	Placenta	Placenta
17	chr19:36351400-36352400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr19:36351400-36352400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr19:36351400-36352400	Bivalent Enhancer	Stomach Mucosa	stomach
20	chr19:36351400-36352600	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
21	chr19:36351400-36352800	Active TSS	H9 Cell Line	embryonic stem cell
22	chr19:36351400-36352800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
23	chr19:36351400-36353000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr19:36351600-36351800	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr19:36351600-36351800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
26	chr19:36351600-36351800	Bivalent Enhancer	Duodenum Mucosa	Duodenum
27	chr19:36351600-36351800	Enhancers	Gastric	stomach
28	chr19:36351600-36352000	Flanking Bivalent TSS/Enh	ES-WA7 Cell Line	embryonic stem cell
29	chr19:36351600-36352000	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr19:36351600-36352000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
31	chr19:36351600-36352000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
32	chr19:36351600-36352400	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
33	chr19:36351600-36352400	Bivalent Enhancer	Colonic Mucosa	Colon
34	chr19:36351600-36352400	Bivalent Enhancer	Esophagus	oesophagus
35	chr19:36351600-36352600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr19:36351600-36352600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
37	chr19:36351600-36352600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
38	chr19:36351600-36352800	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links